Triflusal Triflusal Triflusal is a platelet aggregation inhibitor that was discovered and developed in the Uriach Laboratories, and commercialised in Spain since 1981. Currently, it is available in 25 countries in Europe, Asia, Africa and America. It is a drug of the salicylate family but it is not a derivative of acetylsalicylic acid (ASA). Trade names include Disgren, Grendis, Aflen and Triflux. Triflusal is a selective platelet antiaggregant through; Triflusal is indicated for; In the 2008 guidelines for stroke management from the European Stroke Organization, triflusal was for the first time recommended as lone therapy, as an alternative to acetylsalicylic acid
ASA Late Model Series was renamed the ASA Late Model Challenge Series. As part of the splinter of the American Speed Association caused by the 2004 season, the American Speed Association was broken up. The Late Model Series was reacquired by Varney, while other assets were sold to Racing Speed Associates, led by Dennis Huth. On December, 2007, Dennis Huth filed a lawsuit against the ASA Late Model Series seeking to invalidate and cancel the ASA Late Model Series trademark registration. The ASA Late Model Series responded that the lawsuit is frivolous and without merit and plan counter sue Mr. Huth for damages caused